Cargando…

Could successful (mitochondrial) networking help prevent Huntington's disease?

Polyglutamine expansions in huntingtin (Htt) are known to cause the profound neurodegenerative disorder, Huntington's disease (HD). Mitochondrial dysfunction has long been implicated in the pathophysiology of HD, but the underlying mechanism remains obscure. An article by Costa et al in this mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Jorge M A, Lightowlers, Robert N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2010
Materias:	Closeup
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377349/ https://www.ncbi.nlm.nih.gov/pubmed/21117121 http://dx.doi.org/10.1002/emmm.201000104

Ejemplares similares

Salvaging hope: Is increasing NAD(+) a key to treating mitochondrial myopathy?
por: Lightowlers, Robert N, et al.
Publicado: (2014)

Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease
por: Kazemi-Esfarjani, Parsa, et al.
Publicado: (2010)

In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
por: Murphy, Anne N
Publicado: (2009)

Making the most of what you've got: Optimizing residual OXPHOS function in mitochondrial diseases
por: Moraes, Carlos T
Publicado: (2009)

Mixing and matching mitochondrial aminoacyl synthetases and their tRNAs: a new way to treat respiratory chain disorders?
por: Tyynismaa, Henna, et al.
Publicado: (2014)

A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells
por: Moraes, Carlos T
Publicado: (2014)

Novel non-coding RNA-based therapeutic approaches to prevent statin-induced liver damage
por: Bang, Claudia, et al.
Publicado: (2012)

The heart-liver metabolic axis: defective communication exacerbates disease
por: Baskin, Kedryn K, et al.
Publicado: (2014)

Circulating tumor DNA in early-stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?
por: af Hällström, Taija M, et al.
Publicado: (2015)

Single stem cell gene therapy for genetic skin disease
por: Larsimont, Jean-Christophe, et al.
Publicado: (2015)

A new way APP mismetabolism can lead to Alzheimer's disease
por: Hardy, John, et al.
Publicado: (2011)

New targets for old diseases: lessons from mucolipidosis type II
por: Settembre, Carmine, et al.
Publicado: (2013)

Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology
por: Sands, Mark S
Publicado: (2013)

Divide and conquer: the genetic basis of molecular subclassification of breast cancer
por: Kristensen, Vessela N
Publicado: (2011)

High mobility group box-1 recognition: The beginning of a RAGEless era?
por: Branco-Madeira, Filipe, et al.
Publicado: (2010)

Selecting for predisposition to cancer cachexia
por: Gioulbasanis, Ioannis, et al.
Publicado: (2012)

Hepcidin and iron-mediated resistance to malaria
por: Prentice, Andrew M
Publicado: (2011)

Neurofibromatosis and lessons for the war on cancer
por: Reilly, Karlyne M
Publicado: (2009)

A surrogate marker for Aβ42 production in the CNS
por: Holtzman, David M
Publicado: (2009)

A new twist to the emerging functions of ceramides in cancer: novel role for platelet acid sphingomyelinase in cancer metastasis
por: Hannun, Yusuf A, et al.
Publicado: (2015)

Gaining the hard yard: pre-clinical evaluation of lentiviral-mediated gene therapy for the treatment of β-thalassemia
por: Milsom, Michael D, et al.
Publicado: (2010)

The double-edged sword of fibronectin in atherosclerosis
por: Moore, Kathryn J, et al.
Publicado: (2012)

Heart to heart: grafting cardiosphere-derived cells augments cardiac self-repair by both myocytes and stem cells
por: Palacios, Jose A, et al.
Publicado: (2013)

VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor
por: Favara, David M, et al.
Publicado: (2014)

New TB treatments hiding in plain sight
por: Olive, Andrew J, et al.
Publicado: (2015)

Decoding the evolution of a breast cancer genome
por: Bedard, Philippe L, et al.
Publicado: (2010)

SPAKling insight into blood pressure regulation
por: Castañeda-Bueno, María, et al.
Publicado: (2010)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

Prion protein in Alzheimer's pathogenesis: a hot and controversial issue
por: Benilova, Iryna, et al.
Publicado: (2010)

Inositol-requiring 1/X-box-binding protein 1 is a regulatory hub that links endoplasmic reticulum homeostasis with innate immunity and metabolism
por: Kaufman, Randal J, et al.
Publicado: (2010)

Through a glass darkly
por: Hall, James E
Publicado: (2012)

p63 and FGFR: when development meets proliferation
por: Dotto, G Paolo
Publicado: (2012)

Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer
por: Moserle, Lidia, et al.
Publicado: (2012)

Inhibition of terminal complement activation in severe Shiga toxin-associated HUS – perfect example for a fast track from bench to bedside
por: Orth-Höller, Dorothea, et al.
Publicado: (2011)

Neural stem cells for diabetes cell-based therapy
por: Basak, Onur, et al.
Publicado: (2011)

Parachuting in the epigenome: the biology of gene vector insertion profiles in the context of clinical trials
por: Baum, Christopher
Publicado: (2011)

Inducible and reversible breaching of the blood brain barrier by RNAi
por: Rossi, John J
Publicado: (2011)

Beyond the GWAS in schizophrenia
por: Malhotra, Anil K
Publicado: (2011)

Interferon-lambda as a new approach for treatment of allergic asthma?
por: Edwards, Michael R, et al.
Publicado: (2011)

Circulating miRNA signature for early diagnosis of lung cancer
por: Lin, Pei-Ying, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_us3gv5hmv6no57b58gc8r3kqcv